| Ipc Hospitalists Of New Mexico, Inc | |
|
8208 Louisiana Blvd Ne Ste. C Albuquerque NM 87113-1757 | |
| (602) 789-0344 | |
| (602) 870-7566 |
| Full Name | Ipc Hospitalists Of New Mexico, Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 8208 Louisiana Blvd Ne, Albuquerque, New Mexico |
| Authorized Official Name and Position | R. Jeffrey Taylor (PRESIDENT & COO) |
| Authorized Official Contact | 8187663502 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ipc Hospitalists Of New Mexico, Inc 8208 Louisiana Blvd Ne Ste. C Albuquerque NM 87113-1757 Ph: () - | Ipc Hospitalists Of New Mexico, Inc 8208 Louisiana Blvd Ne Ste. C Albuquerque NM 87113-1757 Ph: (602) 789-0344 |
| NPI Number | 1578839163 |
|---|---|
| Provider Enumeration Date | 03/28/2012 |
| Last Update Date | 04/22/2016 |
| Medicare PECOS PAC ID | 6800051509 |
|---|---|
| Medicare Enrollment ID | O20120703000044 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578839163 | NPI | - | NPPES |
| 27573371 | Medicaid | NM | |
| 889234086 | Other | NM | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Ronald E Sautter |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376577577 PECOS PAC ID: 7911808050 Enrollment ID: I20040120000769 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Mahmood Reza Zamanian |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1386641876 PECOS PAC ID: 6709788292 Enrollment ID: I20040124000065 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Joan Lewis |
|---|---|
| Provider Type | Practitioner - Interventional Pain Management |
| Provider Identifiers | NPI Number: 1538203856 PECOS PAC ID: 4789661497 Enrollment ID: I20040701000198 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Judith Hooffstetter |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1114932506 PECOS PAC ID: 1658329099 Enrollment ID: I20050307000346 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Lara L Goss |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316942501 PECOS PAC ID: 3072584366 Enrollment ID: I20050330000130 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Henry Huson Middleton |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1063419547 PECOS PAC ID: 6204748288 Enrollment ID: I20050414000363 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Robert A Gardner |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1194717801 PECOS PAC ID: 8527087428 Enrollment ID: I20051215000412 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Syed Mahdi |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1134203458 PECOS PAC ID: 1850393083 Enrollment ID: I20070201000066 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | John A Bennett |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1427133065 PECOS PAC ID: 4688761349 Enrollment ID: I20071029000331 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Gail Carman Dela Cruz |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568479079 PECOS PAC ID: 2769585991 Enrollment ID: I20090310000401 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | David B Durham |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1326264623 PECOS PAC ID: 6901986157 Enrollment ID: I20090429000529 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Nooshin Bagheri |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1083753081 PECOS PAC ID: 8729126008 Enrollment ID: I20091105000608 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Eric W Metzler |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1144289851 PECOS PAC ID: 2860435260 Enrollment ID: I20100601000464 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Lisa M Stolarczyk |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1497930176 PECOS PAC ID: 4880874866 Enrollment ID: I20110208000740 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Diana Lucia Darabant |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1538460928 PECOS PAC ID: 5698956068 Enrollment ID: I20110218000510 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Lorraine Olson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1235113689 PECOS PAC ID: 0345424677 Enrollment ID: I20110412000421 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Carol Schaffer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831497288 PECOS PAC ID: 7618093147 Enrollment ID: I20111018000656 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Karam S Bhalla |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1972642973 PECOS PAC ID: 4789847526 Enrollment ID: I20120515000495 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | David G Bowman |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1700873189 PECOS PAC ID: 0749181246 Enrollment ID: I20120703000090 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Kathleen C Voigt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831304047 PECOS PAC ID: 4587610761 Enrollment ID: I20120821000228 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Lynnette Gail Wright |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871569509 PECOS PAC ID: 5597715276 Enrollment ID: I20120904000492 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Jennifer M Ramon |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285971192 PECOS PAC ID: 1759528409 Enrollment ID: I20130516000411 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Susan L Miller |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538262407 PECOS PAC ID: 0648369280 Enrollment ID: I20130611000801 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Cynthia Louise Nielsen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1104248392 PECOS PAC ID: 0840420899 Enrollment ID: I20140313000673 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Jean-paul Dedam |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1649486770 PECOS PAC ID: 4486791001 Enrollment ID: I20140429001842 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Clare M Ironside |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972988392 PECOS PAC ID: 4082923776 Enrollment ID: I20151020001854 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Tani Schare |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831579531 PECOS PAC ID: 7719296060 Enrollment ID: I20151027002767 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Mark J Stevens |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1013145531 PECOS PAC ID: 1254591274 Enrollment ID: I20160621000818 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Dmitriy Vladimirovich Bazaron |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1043728249 PECOS PAC ID: 2567724743 Enrollment ID: I20180328001388 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Mary Louise Blankenship |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356358477 PECOS PAC ID: 1759270770 Enrollment ID: I20180504001349 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Jane-frances Shiti |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215461629 PECOS PAC ID: 9638415078 Enrollment ID: I20191010002673 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
| Provider Name | Timothy John Rodgers |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1215939541 PECOS PAC ID: 8921192089 Enrollment ID: I20200804001775 |
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
News Archive
At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.
A genetic score based on PCa risk-associated single nucleotide polymorphisms is an independent predictor of prostate biopsy outcomes, suggest the results of a new study conducted by a group from the Department of Urology Huashan Hospital, Fudan University in Shanghai, China.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
A self-made millionaire Peter Goodenough who died from motor neuron disease (MND) left more than $6 million to the University's Queensland Brain Institute (QBI) to help find a cure for MND.
› Verified 9 days ago
Double Happiness Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4104 Ponderosa Ave Ne, Albuquerque, NM 87110 Phone: 505-385-4127 Fax: 505-265-5041 | |
Albuquerque Internal Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4121 Montgomery Blvd Ne, Albuquerque, NM 87109 Phone: 505-314-0748 | |
Gabriella Good Md Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3015 Indian Farm Ln Nw, Albuquerque, NM 87107 Phone: 505-259-8694 Fax: 186-660-7177 | |
Hands On Health Care, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3825 Eubank Blvd Ne Ste C, Albuquerque, NM 87111 Phone: 505-298-8020 | |
Medicus Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 10401 Montgomery Pkwy Ne, Albuquerque, NM 87111 Phone: 505-234-1040 Fax: 505-293-7183 | |
New Mexico Neuromuscular Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2741 Indian School Rd Ne, Albuquerque, NM 87106 Phone: 505-255-8682 Fax: 505-255-7890 | |
Lovelace Healthcare Center-rio Bravo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 200 Rio Bravo Blvd Se, Albuquerque, NM 87105 Phone: 505-873-6400 Fax: 505-873-6403 |